Skip to main content
. 2019 Jul 9;104(11):5183–5194. doi: 10.1210/jc.2019-00627

Table 7.

Adjusted RRs of SF-36 Outcomes Between Survivors With Endocrine Conditions Reporting Medication Use for Hormone Replacement Compared With Those Not on Hormone Replacement Therapy

SF-36 Scale or Component Summary Score Survivors with Hypothyroidism on Replacement Therapy at 2003 Survey Compared With Survivors With no Replacement (n = 110)a Males With Gonadal Dysfunction on Testosterone Therapy at 2003 Survey Compared With Survivors With No Replacement (n = 51)a Females With Gonadal Dysfunction on HRT at 2003 Survey Compared With Survivors With No Replacement (n = 168)a
Physical function 1.00 (0.96–1.04) 0.19 (0.04–0.88) 0.90 (0.53–1.55)
Role physical 1.23 (0.61–2.50) 0.71 (0.71–2.53) 1.01 (0.57–1.80)
Bodily pain 1.08 (0.64–1.81) 0.47 (0.15–1.50) 0.84 (0.55–1.26)
General health 0.81 (0.50–1.32) 0.40 (0.14–1.19) 0.85 (0.62–1.15)
Vitality 0.78 (0.50–1.22) 0.54 (0.25–1.18) 0.72 (0.48–1.09)
Role emotional 0.74 (0.48–1.13) 0.38 (0.15–0.98) 1.02 (0.58–1.82)
Social function 0.89 (0.46–1.69) 0.22 (0.05–0.97) 0.99 (0.71–1.38)
Mental health 0.58 (0.36–0.93) 0.22 (0.06–0.86) 1.07 (0.65–1.77)
Physical component summary 0.77 (0.45–1.32) 0.16 (0.02–1.56) 1.09 (0.62–1.91)
Mental component summary 0.75 (0.41–1.36) 0.48 (0.16–1.43) 1.16 (0.62–2.20)

Bold type indicates significant results.

Abbreviation: HRT, hormone replacement therapy.

a

Adjusted for sex (only for testosterone therapy and HRT), race, education, marital status, household income, health insurance, employment status, radiation (yes/no), amputation, and other grade 3 to 4 chronic condition.